Patent · US Active

Methods and compositions for nuclease-mediated targeted integration of transgenes

US10174331B2 · kind B2 · utility

0Cited by

56References

10Claims

0Family size

Assignees

Sangamo Therapeutics, Inc. · US
DOW AGROSCIENCES LLC · US

Inventors

Gregory J. Cost · Berkeley, US
Fyodor Urnov · Richmond, US
W. Michael Ainley · Carmel, US
Joseph F. Petolino · Zionsville, US
Jayakumar P. Samuel · Carmel, US
Steven R. Webb · Westfield, US
Lakshmi Sastry-Dent · Indianapolis, US

Key dates

Filing date	May 7, 2013
Grant date	Jan 8, 2019
Priority date	—
Expiry date	May 31, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A40/146
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for homology-independent targeted insertion of donor molecules into the genome of a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.